Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.9207
+0.02072.30%
Post-market: 0.93860.0179+1.94%19:18 EDT
Volume:253.12K
Turnover:237.40K
Market Cap:43.09M
PE:-1.31
High:0.9998
Open:0.9000
Low:0.8951
Close:0.9000
52wk High:2.93
52wk Low:0.8639
Shares:46.80M
Float Shares:19.94M
Volume Ratio:1.34
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7050
EPS(LYR):-0.7584
ROE:-142.60%
ROA:-68.49%
PB:0.99
PE(LYR):-1.21

Loading ...

Company Profile

Company Name:
InspireMD
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
127
Office Location:
6303 Waterford District Drive,Suite 215,Miami,Florida,United States
Zip Code:
33126
Fax:
- -
Introduction:
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Directors

Name
Position
Marvin Slosman
Director, President and Chief Executive Officer
Paul Stuka
Non-Executive Chairman of the Board
Gary Roubin
Independent Director
Michael Berman
Independent Director
Scott R. Ward
Independent Director
Danny Lee Dearen
Director
Raymond W. Cohen
Director

Shareholders

Name
Position
Marvin Slosman
Director, President and Chief Executive Officer
Andrea Tommasoli
Chief Operating Officer
Michael A. Lawless
Chief Financial Officer
Patrick Verta
Executive Vice President, Clinical and Medical Affairs
Pete Ligotti
Executive Vice President and General Manager of U.S.
Shane Gleason
Chief Commercial Officer